Abstract
This review article has gathered different types of electrode modification with a brief introduction given to explain several phenomena occurring at chemically modified electrodes and the mechanism of detection, followed by some interesting applications of chemically modified electrodes (CMEs) in pharmaceutical analysis, emphasizing on the biosensors and CNT-based chemical sensors.
Keywords: Modified electrodes, pharmaceutical, biosensors, carbon nanotubes
Combinatorial Chemistry & High Throughput Screening
Title: Recent Updates of Chemically Modified Electrodes in Pharmaceutical Analysis
Volume: 13 Issue: 8
Author(s): Abd-Elgawad Radi
Affiliation:
Keywords: Modified electrodes, pharmaceutical, biosensors, carbon nanotubes
Abstract: This review article has gathered different types of electrode modification with a brief introduction given to explain several phenomena occurring at chemically modified electrodes and the mechanism of detection, followed by some interesting applications of chemically modified electrodes (CMEs) in pharmaceutical analysis, emphasizing on the biosensors and CNT-based chemical sensors.
Export Options
About this article
Cite this article as:
Radi Abd-Elgawad, Recent Updates of Chemically Modified Electrodes in Pharmaceutical Analysis, Combinatorial Chemistry & High Throughput Screening 2010; 13 (8) . https://dx.doi.org/10.2174/138620710791920338
DOI https://dx.doi.org/10.2174/138620710791920338 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Novel Targets for Cardiac Antiarrhythmic Drug Development
Current Pharmaceutical Design Development of Inhibitors of the Aspartyl Protease Renin for the Treatment of Hypertension
Current Protein & Peptide Science Pharmacological Treatment of Diabetic Peripheral Neuropathy: An Update
CNS & Neurological Disorders - Drug Targets Development of Proteinase-Activated Receptor 1 Antagonists as Therapeutic Agents for Thrombosis, Restenosis and Inflammatory Diseases
Current Pharmaceutical Design Defining Pharmacokinetics for Individual Patient Dosimetry in Routine Radiopeptide and Radioimmunotherapy of Cancer: Australian Experience
Current Pharmaceutical Design Effects of Statins on Blood Pressure: A Review of the Experimental and Clinical Evidence.
Current Vascular Pharmacology Clinical Trials for Acute Kidney Injury: Design Challenges and Possible Solutions
Current Drug Targets Drug Delivery Systems for Imaging and Therapy of Parkinson's Disease
Current Neuropharmacology Fourth Generation of Synthetic Cannabinoid Receptor Agonists: A Review on the Latest Insights
Current Pharmaceutical Design Invited Editorial: Malaria by <i>Plasmodium knowlesi</i>, A Zoonosis Transmitted by Vectors
Recent Patents on Anti-Infective Drug Discovery Hypotensive Agents from Snake Venoms
Current Drug Targets - Cardiovascular & Hematological Disorders Biologicals Dramatic Advances in the Treatment of Psoriasis
Current Pharmaceutical Design Perioperative Considerations in Diabetic Patients
Current Diabetes Reviews Combination of Statin Plus Renin Angiotensin System Inhibition for the Prevention or the Treatment of Atherosclerotic Cardiovascular Disease
Current Pharmaceutical Design Food Allergy
Current Pharmaceutical Design New Therapies for Patients with Chronic Lymphocytic Leukemia
Current Cancer Therapy Reviews An Exceptional Case of Atrial Fibrillation Arrhythmia Induced by Etoposide
Current Drug Safety Targeting of Nuclear Factor-κB and Proteasome by Dithiocarbamate Complexes with Metals
Current Pharmaceutical Design Use of Medication in Coronary Imaging by CT
Current Medical Imaging Mineralocorticoid Antagonists in ESRD: An Overview of Clinical Trial Evidence
Current Vascular Pharmacology